The Community Patent: What This Means for the Pharmaceutical Industry

By Cohen L.J.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 1, 2003-01 ,pp. : 3-10

Adis International

Access to resources Recommend Favorite

Inventors and their attorneys must beware of their actions before the US Patent and Trademark Office

By Warburg Richard   Nguyen Lauren  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 453-456

Informa Healthcare

Access to resources Recommend Favorite

Tissue engineering: a historical review as seen through the US Patent Office

By Pabst Patrea L  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 347-352

Informa Healthcare

Access to resources Recommend Favorite

Inventors and their attorneys must beware of their actions before the US Patent & Trademark Office

By Warburg Richard   Nguyen Lauren  

Pharmacogenomics, Vol. 5, Iss. 2, 2004-03 ,pp. : 143-147

Future Medicine

Access to resources Recommend Favorite

New antibacterials for the treatment of toxoplasmosis; a patent review

By Rodriguez Juan Bautista   Szajnman Sergio Hernán  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 311-333

Informa Healthcare

Access to resources Recommend Favorite